c-myb activates CXCL12 transcription in T47D and MCF7 breast cancer cells

Acta Biochim Biophys Sin (Shanghai). 2010 Jan;42(1):1-7. doi: 10.1093/abbs/gmp108.

Abstract

Chemokine C-X-C motif ligand 12 (CXCL12) is a potent chemotactic and angiogenic factor that has been proposed to play a role in organ-specific metastasis and angiogenic activity in several malignancies. In this study, we found that the overexpression of c-myb could elevate CXCL12 mRNA level and CXCL12 promoter activity in human T47D and MCF-7 breast cancer cells. Chromatin immunoprecipitation assay demonstrated that c-myb could bind to the CXCL12 promoter in the cells transfected with cmyb expression vector. c-myb siRNA attenuated CXCL12 promoter activity and the binding of c-myb to the CXCL12 promoter in T47D and MCF-7 cells. These results indicated that c-myb could activate CXCL12 promoter transcription.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Cell Line, Tumor
  • Chemokine CXCL12 / genetics*
  • Chemokine CXCL12 / metabolism
  • Chromatin Immunoprecipitation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Promoter Regions, Genetic / physiology*
  • Proto-Oncogene Proteins c-myb / pharmacology*
  • Proto-Oncogene Proteins c-myb / physiology
  • RNA, Messenger / metabolism
  • Regulatory Sequences, Nucleic Acid / drug effects
  • Transcriptional Activation / drug effects*

Substances

  • Chemokine CXCL12
  • Proto-Oncogene Proteins c-myb
  • RNA, Messenger